Page 38 - First Five News Today : Breaking News, Live Updates & Top Stories | Vimarsana

'I want people to see that, hey, I'm OK' | A week after vaccination, one of DC's 'First Five' reports no ill effects Lt. Keishea Jackson says she hopes others will follow her example and get the coronavirus vaccine once it's available. Author: Jordan Fischer Updated: 5:11 PM EST December 24, 2020 WASHINGTON — “What was it like to finally get the shot?” Lt. Keishea Jackson said. “It was so many feelings. I was apprehensive. Not really scared. At the end of it was definitely relief.” Jackson, an 18-year veteran of DC Fire & EMS, was one of the so-calle...

Updated on December 16, 2020 at 7:07 pm NBC Universal, Inc. D.C. firefighters and first responders will be getting vaccinated Thursday as part of a citywide effort to boost confidence in the new COVID-19 vaccine.  The first emergency responders to receive the Pfizer vaccine, which arrived Wednesday, have been dubbed “The First Five.” They are D.C.’s Fire Chief John Donnelly, the department’s medical director Dr. Robert Holman, and three firefighters, Lieutenants Joseph Papariello and Keishea Jackson, and firefighter/EMT Julio Quinteros. For Jackson, it’s about building public trust...

COVID-19 vaccine begins arriving in the District Published  DC includes Fire & EMS in first round of vaccines Mayor Muriel Bowser announced today that D.C. Fire & EMS members will be among the first to receive the Pfizer coronavirus vaccine in the District. Five volunteers have been selected to be the first candidates on Thursday. WASHINGTON (FOX 5 DC) - The first batch of the COVID-19 vaccine arrived in the United States overnight – and it has been sent to several locations in the District. The District will receive 6,825 doses of the vaccine during the initial allotment. Six sit...

Reply NEW HAVEN, CT — Pharmaceutical giant AstraZeneca announced that it will acquire former Connecticut-based Alexion Pharmaceuticals. Alexion shareholders will receive $60 in cash per share plus the equivalent of about one AstraZeneca share — the deal works out to a total of $39 billion or around $175 per Alexion share. The boards of both companies have approved the acquisition and it is still subject to regulatory clearances and approval by shareholders of both companies. The deal is expected to close in the third quarter of 2021. Subscribe Alexion specializes in pharmaceuticals for im...